Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Preliminary Evidence on the Efficacy and Tolerability of Quetiapine in Dual Disorders: A Prospective, Multicentric, Real-World StudyAlessio Mosca, Clara Cavallotto, Stefania Chiappini, et al.
Translational Psychiatry|November 1, 2025
Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changesGiacomo d'Andrea, Stefania Chiappini, Laura Ciavoni, et al.
European Addiction Research|June 5, 2023
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young AdultsFrancesco Di Carlo, Valeria Verrastro, Maria Chiara Alessi, et al.
Molecular Psychiatry|January 4, 2024
Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorderMauro Pettorruso, Andrea Miuli, Katia Clemente, et al.
International Journal of Molecular Sciences|April 30, 2021
Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and TreatmentLorenza Lucidi, Mauro Pettorruso, Federica Vellante, et al.
Frontiers in Public Health|July 4, 2024
Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdownIlaria De Luca, Francesco Di Carlo, Julius Burkauskas, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 26, 2026
Dopaminergic dysfunction in substance-related and behavioral addictions: Evidence from SPECT imaging in alcohol and gambling disordersMauro Pettorruso, Daniela Di Giuda, Fabrizio Cocciolillo, et al.
Frontiers in Psychiatry|October 26, 2020
Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in ItalyGiovanni Martinotti, Maria Chiara Alessi, Chiara Di Natale, et al.
Pageof 7